Canada markets closed

Sutro Biopharma, Inc. (STRO)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
4.6950+0.6850 (+17.10%)
As of 11:28AM EDT. Market open.
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Cash flows from operating activities
Net Income
-114,956
-106,793
-119,204
-105,538
-32,128
Depreciation & amortization
6,962
6,816
5,690
4,844
4,297
Stock based compensation
24,955
24,908
26,304
23,241
11,917
Change in working capital
-26,580
-34,375
104,405
-17,620
-11,486
Accounts receivable
-21,427
-28,956
5,341
-6,895
739
Accounts Payable
2,717
4,812
-1,225
2,708
-1,141
Other working capital
-119,185
-115,931
-4,309
-97,002
-74,931
Other non-cash items
24,786
16,820
2,922
6,159
606
Net cash provided by operating activites
-115,366
-111,616
3,549
-81,679
-67,802
Cash flows from investing activities
Investments in property, plant and equipment
-3,819
-4,315
-7,858
-15,323
-7,129
Purchases of investments
-542,538
-460,301
-216,671
-248,727
-130,741
Sales/Maturities of investments
539,087
460,692
189,498
166,726
138,385
Other investing activites
-
-
9
9
89
Net cash used for investing activites
-7,270
-3,924
-35,022
-97,315
604
Cash flows from financing activities
Debt repayment
-13,458
-12,500
-9,375
0
-10,000
Common stock issued
1,048
11,971
56,270
0
251,415
Common stock repurchased
-
0
0
-7
0
Other financing activites
135,795
135,718
-463
-987
-314
Net cash used privided by (used for) financing activities
125,367
137,554
48,313
3,256
269,247
Net change in cash
2,731
22,014
16,840
-175,738
202,049
Cash at beginning of period
63,344
48,126
31,286
207,024
4,975
Cash at end of period
66,075
70,140
48,126
31,286
207,024
Free Cash Flow
Operating Cash Flow
-115,366
-111,616
3,549
-81,679
-67,802
Capital Expenditure
-3,819
-4,315
-7,858
-15,323
-7,129
Free Cash Flow
-119,185
-115,931
-4,309
-97,002
-74,931